Neura Market
Quibim logo

Quibim

Paid

Transforming imaging data into actionable predictions

4.5
New AI ToolsContact
Type
Saas
Company
Quibim
Visit Website
LinksXLinkedIn

About Quibim

Quibim applies artificial intelligence to medical imaging (MRI, CT, PET) to extract radiomics biomarkers and actionable predictions. Their cloud-based, tissue-agnostic platform (QP-Insights) handles imaging data management, harmonization, and automated extraction of radiomics and deep features for clinical research and drug development. The company offers FDA/CE-cleared software products for specific clinical areas: QP-Prostate (prostate MRI analysis with PI-RADS compliance), QP-Brain (brain volumetry and white matter hyperintensity analysis), and QP-Liver (fat and iron quantification for liver disease). Quibim partners with biopharma companies for value-based collaborations and provides SaaS to healthcare providers, all with ISO 27001, HIPAA, and GDPR compliance.

Key Features

Cloud-based, tissue-agnostic platform (QP-Insights) for imaging data management and harmonization
Automated extraction of radiomics and deep features for imaging biomarker discovery
AI-powered products: QP-Prostate (prostate MRI, PI-RADS compliance), QP-Brain (volumetry, WMH analysis), QP-Liver (fat/iron quantification)
Data security by design: ISO 27001:2022 certified, HIPAA and GDPR compliant, encrypted storage and transfer
Integration with PACS for clinical workflow and with EHR data for multi-omics studies
Scalable cloud infrastructure on Microsoft Azure with secure data storage

Pros & Cons

Pros
  • Proven clinical products with specific compliance (PI-RADS) and regulatory clearances
  • End-to-end platform covering data management, harmonization, and AI analysis
  • Strong security and privacy certifications (ISO 27001, HIPAA, GDPR)
  • Value-based partnerships with biopharma for real-world evidence generation
  • Tissue-agnostic approach applicable to multiple organs and diseases
Cons
  • Primarily designed for medical imaging workflows, not a general-purpose AI platform
  • Pricing requires direct contact; no transparent starting price available
  • Dependence on cloud connectivity and integration with existing hospital systems

Best For

Drug development: identify clinical trial candidates, predict response, monitor toxicity via AI modelsClinical diagnosis: streamline prostate MRI reads, aid brain diagnosis with volumetry, personalize liver disease managementResearch: correlate imaging data with EHR and multi-omics data to develop new predictive models and biomarkersRadiology workflow automation: automated segmentation and quantification to reduce manual effort

Alternatives to Quibim

PlugSugar

Automate conversations, answer questions with Web Search plugin, and customize ChatGPT experience using powerful AI plugins.

100DaysOfAI Challenge

Respage

Automate lead acquisition, interact with potential leads, and capture lead information and preferences.

Travel Plan AI

Your personal AI guide for unforgettable journeys.

3D Avataaars Generator

Create custom avatars for storytelling, game development, and marketing campaigns with ease.

AnimateDiff

FAQ

What types of medical images does Quibim support?
Quibim works with MRI, CT, and PET imaging data. Their platform is tissue-agnostic and can analyze images from various anatomical regions.
Is Quibim compliant with healthcare data regulations?
Yes. Quibim is ISO 27001:2022 certified and ensures compliance with HIPAA and GDPR. Data is encrypted during storage and transfer, and they use Microsoft Azure's secure cloud infrastructure.
What are Quibim's main products?
Quibim offers three main software-as-medical-device products: QP-Prostate (prostate MRI analysis with PI-RADS compliance), QP-Brain (brain volumetry and white matter hyperintensity analysis), and QP-Liver (fat and iron quantification for liver disease). They also have the QP-Insights platform for research.
How does Quibim help in drug development?
Quibim partners with biopharma companies to identify candidates for clinical studies, select patients likely to respond to a drug, and monitor toxicity and adverse events using AI models that analyze imaging data.